Key Insights

Highlights

Treatment Research

2 treatments under study, led by Dcycloserine 100 Mg

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 2 (2)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
SYF1002ecea088f40a687922dfc97e56dcaPhase 2Recruiting

Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial (PreKET)

SYF71f612249cb44ee0bffce2968f5121d1Phase 2Recruiting

AIDA-DEP - Accelerated Intermittent theta-burst stimulation with D-cycloserine Augmentation for DEPression - a multicenter, randomized, placebo-controlled, double-blind clinical trial

Showing all 2 trials

Research Network

Common Treatments

  • Dcycloserine 100 Mg1
  • The Placebo Product Is A Size 1 Opaque Orange Hard Gelatine Capsule Identical In Appearance And Similar Weight To The Imp The Placebo Capsules Will Be Filled With Microcrystalline Cellulose1

Active Sponsors

  • Ostfold Hospital Trust1
  • Region Uppsala1

Related Conditions

  • Major Depression1

Activity Timeline